RepliCel Life Sciences Forward P/E
What is the Forward P/E of RepliCel Life Sciences?
The Forward P/E of RepliCel Life Sciences, Inc. is -2.08
What is the definition of Forward P/E?
Forward price to earnings ratio is the ratio of a company’s stock price to the company’s estimated earnings per share for the next twelve months.
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
Forward P/E of companies in the Health Care sector on TSXV compared to RepliCel Life Sciences
What does RepliCel Life Sciences do?
RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual's own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company's product candidates include RCT-01, which has completed Phase I clinical trials for the treatment of chronic tendinosis; RCS-01 that is in Phase 2 clinical trials to treat aging and sun damaged skin; and RCH-01, which is in Phase 2 clinical trials for the treatment of hair loss. It is also developing RCI-02, a dermal injection device. The company has a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. for establishing a clinical research program to develop and commercialize RCS-01 and RCT-01; and collaboration and technology transfer agreement with Shiseido Company, Limited for establishing a clinical research program for RCH-01. It also has a collaboration research project agreement with the University of British Columbia to build a hair follicle cell data map. RepliCel Life Sciences Inc. is headquartered in Vancouver, Canada.
Companies with forward p/e similar to RepliCel Life Sciences
- Eastern Platinum has Forward P/E of -2.18
- Big Lots Inc has Forward P/E of -2.14
- Omeros has Forward P/E of -2.13
- Wealth Minerals has Forward P/E of -2.12
- Industrial Logistics Properties Trust has Forward P/E of -2.11
- Transgene SA has Forward P/E of -2.10
- RepliCel Life Sciences has Forward P/E of -2.08
- Ekso Bionics Inc has Forward P/E of -2.07
- Fuelcell Inc has Forward P/E of -2.07
- Arcutis Biotherapeutics Inc has Forward P/E of -2.07
- CytomX Therapeutics Inc has Forward P/E of -2.06
- Kaleyra Inc has Forward P/E of -2.05
- Fermentalg SA has Forward P/E of -2.04